Sorry, you need to enable JavaScript to visit this website.
Skip to main content


IDWeek 2021 Newsroom

IDWeek 2021
Our Commitment to Combating Infectious Diseases
IDWeek 2021
Our Commitment to Combating Infectious Diseases

Welcome to the Janssen Infectious Diseases & Vaccines IDWeek 2021 Newsroom

Janssen’s Commitment to Combating Infectious Diseases
A Message from Penny Heaton and James Merson

At Janssen, we have a strong legacy of delivering medicines and vaccines to contribute to global efforts to fight infectious diseases, one of the greatest threats currently facing humankind. Even before the COVID-19 pandemic, infectious diseases accounted for 15% of all deaths worldwide each year.i With infectious diseases disproportionately impacting the most vulnerable populations, we remain committed to building upon our strong foundation of scientific expertise as we aim to tackle the most complex infectious diseases. We have an ambitious goal – to ensure a future where we can prevent the spread of infectious diseases and eliminate the burden they place on global health. We believe our transformational vaccines and therapies will play a vital role in improving outcomes for those who are most in need, across a wide range of infectious diseases.

Learn more below about our pipeline as well as our efforts to help raise awareness of the importance of combating infectious diseases with innovative medicines and vaccines.

Penny Heaton, M.D.
Global Therapeutic Area Head, Vaccines

James Merson, Ph.D.
Global Therapeutic Area Head, Infectious Diseases

IDWeek Highlights


Our Commitment to Combating Infectious Diseases


Our Focus Areas


i World Health Organization. Projections of mortality and causes of death, 2016 to 2060 – Global summary projections. Available at: Last accessed: August 2021.